Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients

Type 2 diabetes (T2DM) is a major public health problem worldwide. It is estimated that 366 million people will be affected by T2DM till the year of 2030[1,2]. Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes. The lifetime incidence of DPN is approximately 45% for patients with type 2 diabetes mellitus and 54% to 59% for patients with type 1 diabetes mellitus [3,4]. In China, peripheral neuropathy is demonstrated to be popular among diabetics, pre-diabetics and even among normal population [5].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research